Plasma pharmacokinetics and intrapulmonary penetration of tebipenem in healthy subjects Posted on April 21, 2022 at 8:05 am.Written by SPERO THERAPEUTICS Written by: Keith Rodvold, PharmD (University of Illinois Chicago) View Presentation Post navigation Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model
